We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

EU Eyeing Opening Markets For Biosimilar, Generic Drugs

Law360 (January 18, 2019, 11:42 PM EST) -- The European Union is developing a draft regulation that would allow continent-based makers of generic and biosimilar drugs to manufacture their versions of protected drugs for exportation to foreign markets where...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.